List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 11 studies with search of: "Novacea" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Solid Malignancies;   Non-Hodgkin's Lymphoma
Intervention: Drug: AQ4N
2 Recruiting AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: AQ4N;   Drug: Temozolomide;   Procedure: Radiotherapy
3 Active, not recruiting Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndrome
Intervention: Drug: DN-101 (calcitriol)
4 Terminated DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
Condition: Prostate Cancer
Interventions: Drug: calcitriol;   Drug: docetaxel
5 Active, not recruiting Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia
Conditions: Non-Hodgkin's Lymphoma;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Leukemia
Intervention: Drug: AQ4N (Chemotherapy)
6 Completed A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies
Condition: Neoplasms
Intervention: Drug: DN-101
7 Suspended A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: placebo + gemcitabine + erlotinib;   Drug: Placebo + gemcitabine;   Drug: calcitriol + gemcitabine;   Drug: calcitriol + gemcitabine + erlotinib
8 Active, not recruiting Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Conditions: Androgen Independent Prostate Cancer (AIPC);   Non Small Cell Lung Cancer (NSCLC)
Intervention: Drug: DN-101 (calcitriol) - Drug
9 Active, not recruiting ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
Condition: Prostate Cancer
Interventions: Drug: calcitriol;   Drug: docetaxel
10 Completed Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: calcitriol + docetaxel
11 Suspended A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: DN-101;   Drug: Naproxen (Naprosyn)

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services